Lorlatinib vs Trastuzumab

## Lorlatinib vs Trastuzumab: Overview

This comparison examines the pharmacological differences between **Lorlatinib** and **Trastuzumab**.

## Mechanism of Action

**Trastuzumab**: Anti-HER2 monoclonal antibody inhibiting receptor signaling.

## Pharmacokinetics

**Half-life**: Lorlatinib — N/A; Trastuzumab — 28 days.

## Chemical Properties

**Type**: Lorlatinib — Small molecule; Trastuzumab — Antibody.